Cargando…

NLRC5 affects diet-induced adiposity in female mice and co-regulates peroxisome proliferator-activated receptor PPARγ target genes

Nucleotide-binding and oligomerization domain containing 5 (NLRC5) is the key transcriptional regulator of major histocompatibility (MHC) class I genes. Recent observations suggest a role for NLRC5 in metabolic traits and in transcriptional regulation beyond MHC class I genes. To understand the func...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauer, Sarah, Aeissen, Vanessa, Bubeck, Alena M., Kienes, Ioannis, Ellwanger, Kornelia, Scheurenbrand, Mona, Rexhepi, Fjolla, Ramanathan, Sheela, Rosenstiel, Philip, Fricke, W. Florian, Kufer, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034470/ https://www.ncbi.nlm.nih.gov/pubmed/36968073 http://dx.doi.org/10.1016/j.isci.2023.106313

Ejemplares similares

NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis
por: Quenum, Akouavi Julite I., et al.
Publicado: (2021)

NOD-like Receptors—Emerging Links to Obesity and Associated Morbidities
por: Bauer, Sarah, et al.
Publicado: (2023)

XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures
por: Ellwanger, Kornelia, et al.
Publicado: (2019)

NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity
por: Santharam, Madanraj Appiya, et al.
Publicado: (2023)

NLRC5, at the Heart of Antigen Presentation
por: Neerincx, Andreas, et al.
Publicado: (2013)

NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytes
por: Rodriguez, Galaxia M., et al.
Publicado: (2016)

NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ
por: Luan, Peipei, et al.
Publicado: (2019)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

PPARα-mediated peroxisome induction compensates PPARγ-deficiency in bronchiolar club cells
por: Karnati, Srikanth, et al.
Publicado: (2018)

DDX3X Links NLRP11 to the Regulation of Type I Interferon Responses and NLRP3 Inflammasome Activation
por: Kienes, Ioannis, et al.
Publicado: (2021)

Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation
por: Kienes, Ioannis, et al.
Publicado: (2021)

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
por: Wang, Limei, et al.
Publicado: (2014)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) in vitro
por: Alexander, Stephen PH, et al.
Publicado: (2012)

PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2014)

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders
por: Ren, Ping, et al.
Publicado: (2015)

The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy
por: Shukla, Akhil, et al.
Publicado: (2021)

A Novel Splicing Variant of Peroxisome Proliferator-Activated Receptor-γ (Pparγ1sv) Cooperatively Regulates Adipocyte Differentiation with Pparγ2
por: Takenaka, Yasuhiro, et al.
Publicado: (2013)

IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of Listeria monocytogenes
por: Nandi, Madhuparna, et al.
Publicado: (2021)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARγ Agonism as Preventive Pharmacological Approach
por: Zanardelli, Matteo, et al.
Publicado: (2014)

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
por: Heudobler, Daniel, et al.
Publicado: (2018)

NLRC5 Functions beyond MHC I Regulation—What Do We Know So Far?
por: Benkő, Szilvia, et al.
Publicado: (2017)

Bacterial subversion of NLR-mediated immune responses
por: Kienes, Ioannis, et al.
Publicado: (2022)

Peroxisome proliferator-activated receptors (PPARα, PPARγ and PPARβ/δ) gene expression profile on ram spermatozoa and their relation to the sperm motility
por: Kadivar, Ali, et al.
Publicado: (2016)

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists
por: Liberato, Marcelo Vizoná, et al.
Publicado: (2012)

Triflumizole Is an Obesogen in Mice that Acts through Peroxisome Proliferator Activated Receptor Gamma (PPARγ)
por: Li, Xia, et al.
Publicado: (2012)

Peroxisome proliferator‐activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
por: Fumery, Mathurin, et al.
Publicado: (2017)

Peroxisome Proliferator Activator Receptor (PPAR)-γ Ligand, but Not PPAR-α, Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver
por: El-Sheikh, Azza A. K., et al.
Publicado: (2014)

The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages
por: Luo, Yuqian, et al.
Publicado: (2020)

New Target Genes for the Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Antitumour Activity: Perspectives from the Insulin Receptor
por: Foti, Daniela P., et al.
Publicado: (2009)

Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
por: O'Sullivan, Saoirse E., et al.
Publicado: (2009)

Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
por: Green, David E., et al.
Publicado: (2011)

Molecular Modeling of Allosteric Site of Isoform-Specific Inhibition of the Peroxisome Proliferator-Activated Receptor PPARγ
por: Almahmoud, Suliman, et al.
Publicado: (2022)

The involvement of peroxisome proliferator-activated receptor gamma (PPARγ) in anti-inflammatory activity of N-stearoylethanolamine
por: Kosiakova, H., et al.
Publicado: (2022)

NOD1 modulates IL-10 signalling in human dendritic cells
por: Neuper, Theresa, et al.
Publicado: (2017)

Ligand Binding Reduces SUMOylation of the Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation Function 1 (AF1) Domain
por: Diezko, Rolf, et al.
Publicado: (2013)

The Peroxisome Proliferator-activated Receptor γ (PPARγ) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis
por: Benedusi, Valeria, et al.
Publicado: (2012)

The C1431T polymorphism of peroxisome proliferator activated receptor γ (PPARγ) is associated with low risk of diabetes in a Pakistani cohort
por: Butt, Huma, et al.
Publicado: (2016)

Genotyping of peroxisome proliferator-activated receptor gamma (PPAR-γ) polymorphism (Pro12Ala) in Iranian population
por: Namvaran, Fatemeh, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s0usi9q9u4b9efp481pe5s6ogg